Brought to you by

SentreHEART gets $26mm through its Series C round
28 Sep 2016
Executive Summary
SentreHEART Inc. (tissue closure device) has raised $26mm through its Series C venture round to four investors, including US Venture Partners and Prospect Ventures.
Deal Industry
- Medical Devices
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com